Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors
2005; Springer Nature; Volume: 18; Issue: 1 Linguagem: Inglês
10.1038/sj.ijir.3901420
ISSN1476-5489
AutoresMark J. Dresser, Dhaval Desai, Shalini Gidwani, A D Seftel, Nishit B. Modi,
Tópico(s)Urinary Bladder and Prostate Research
Referência(s)